Press Release: Avella : Avella Selected by Array BioPharma Inc. to distribute BRAFTOVI (encorafenib) and MEKTOVI® (binimetinib)

PHOENIX, June 28, 2018 /PRNewswire/ -- Avella has announced that it will distribute BRAFTOVITM (encorafenib and MEKTOVI® (binimetinib), a combination therapy recently FDA approved for patients for the treatment of patients with unresectable or metastatic melanoma with a BRAFV600E or...